Avanti Polar Lipids Inc

Soluble Biotech, now known as Predictive Oncology, is a leading company in Birmingham, AL that specializes in drug discovery and development for oncology. Their innovative solutions include AI-driven biobank technology, 3D tumor models, and formulation services to identify high-solubility and high-stability formulations for biologics. With a focus on bringing the human element into oncology drug development, they aim to revolutionize the field of radiation oncology through strategic partnerships and clinical research services. Predictive Oncology's expertise lies in tumor drug-response genomic biomarker testing, providing valuable information and resources for clinicians and patients. Their team of passionate and creative professionals is dedicated to accelerating the development of biologics, streamlining formulation processes, and ultimately getting drugs to clinical trials faster and easier. With a strong leadership and board, Predictive Oncology is at the forefront of advancing oncology research and making a significant impact in the fight against cancer.Generated from the website

Endomimetics LLC, based in Birmingham, AL, is dedicated to enhancing patient care through the innovation of surgical and implantable medical devices. Utilizing their proprietary Bionanomatrix technology, the company aims to improve healing performance, reduce complications, and extend the functionality of medical implants. Founded by physician-scientists from the University of Alabama at Birmingham, Endomimetics focuses on creating customizable solutions across various medical disciplines, including cardiovascular health, orthopedics, and dental applications. Their Bionanomatrix technology promotes biocompatibility, accelerates recovery, and minimizes common post-operative complications, thereby advancing the standards of patient care. Generated from the website

Technology Commercialization Partners LLC (TCP), based in Birmingham, AL, is a consortium of seasoned biotechnology entrepreneurs dedicated to assisting technology creators and burgeoning companies in transforming innovative ideas into market-ready products and services. The TCP team is well-versed in the commercialization of technologies across various sectors, including drug development, life sciences, medical devices, and analytical instrumentation. With a focus on empowering inventors, TCP leverages its extensive experience in bringing cutting-edge technologies to market, ensuring that advancements in medical science and healthcare are effectively realized and accessible. This commitment to fostering innovation positions TCP as a pivotal resource for startups aiming to navigate the complexities of technology commercialization. Generated from the website